BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Under'. (Return)

Reuters BusinessNov 21, 2019
Shares falter as China-U.S. row over Hong Kong wrecks trade deal hopes
Global stocks took a beating on Thursday as a fresh row between Washington and Beijing over U.S. legislation on Hong Kong threatened to undermine their trade talks and delay a "phase one" deal that investors had initially hoped to be signed by now.

RELATED ARTICLES
GLOBAL MARKETS-Shares falter as China-U.S. row over Hong Kong wrecks trade deal hopes (Reuters Company News)

Google Business NewsNov 20, 2019
Questions of Prince Andrew's billionaire lifestyle arise amid his public retreat - New York Post
Questions of Prince Andrew's billionaire lifestyle arise amid his public retreat  New York Post Prince Andrew Makes Shocking Move to Quit Royal Duties After Explosive Jeffrey Epstein Interview  PEOPLE.comPrince under pressure: Is this the end for Andrew?  Sky NewsPrince Andrew Opens the Door to a Slimmed-Down Monarchy  Bloomberg

RELATED ARTICLES
Prince Andrew should contact US investigators - Epstein victims' lawyer - BBC News (Google Business News)

Yahoo BusinessNov 20, 2019
Hedge Fund Innovator Joseph Edelman Doubles Down on These 3 Biotech Stocks
More than 500 biotech companies operate in the US, doing their part to make it the world's hub for innovation. Only about 20 of them turn a profit, though, highlighting the dangers of the biotech sector. High overhead, long research terms, and the uncertainties of clinical testing and regulatory approval all weigh on them, making biotech at once the riskiest and most potentially profitable of the stock market's segments.Enter Joseph Edelman. The hedge fund veteran started Perceptive Advisors back in 1999 with just $6 million, and his hedge has grown to hold over $5 billion in assets under management today. Edelman's fund's flagship, the Perceptive Life Sciences Fund, specializes in small- and mid-cap biotech companies. That Edelman knows how to spot the winners is clear from the Life Sciences Fund's annualized gains of 30% since its inception.In the words of Brad Loncar, of Loncar Investments, biotech is the "most volatile sector in the stock market… More so than any industry, it's important to be diversified... Even excellent companies with great science fail all the time and have big setbacks, because it's that difficult of a business." Edelman has thrived in this difficult business for the last twenty years, and in his most recent 13F filing, for the quarter ending this past September 30, he doubled down on three companies.We've looked up each in the TipRanks database, to find a line on why.Amarin Corporation (AMRN)A mid-cap company, valued at $7 billion, Amarin is the largest

Yahoo BusinessNov 20, 2019
Fed Throws the Kitchen Sink at Short Rates and Still Struggles
(Bloomberg Opinion) -- "I think we have it under control."That's what Federal Reserve Chair Jerome Powell said when lawmakers in Washington asked him last week about the mid-September turmoil in short-term funding markets. New York Fed President John Williams said something similar on Tuesday. If Powell didn't sound entirely sure, it's for good reason — the Federal Open Market Committee apparently isn't, either. Minutes of the FOMC's October meeting released on Wednesday showed that officials are puzzled about how to best regain their handle on short-term interest rates. According to the minutes, policy makers were presented with two possible options: either frequent repo operations like the past two months, or establishing a standing fixed-rate facility.Fed officials hemmed and hawed:"Many participants noted that, once an ample supply of reserves is firmly established, there might be little need for a standing repo facility or for frequent repo operations. Some of these participants indicated that a basic principle in implementing an ample-reserves framework is to maintain reserves on an ongoing basis at levels that would obviate the need for open market operations to address pressures in funding markets in all but exceptional circumstances. Many participants remarked, however, that even in an environment with ample reserves, a standing facility could serve as a useful backstop to support control of the federal funds rate in the event of outsized shocks to the system.… A couple of other participants sugg
TRENDING TAGS
TrumpChina Apple Kong bill Hong
tradedeal US-China year China report
KongHong bill Trump trade deal
dealtrade Black Friday US-China Best
stocktrade deal Market US-China report
Stockstrade deal US-China report &
Chinatrade US-China deal Trump Kong
HongKong bill Trump trade deal
earningsCall Transcript Q3 Edited conference
AppleTrump Texas billion plant tariffs

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2019 CEOExpress Company LLC